Patents-Review.com
ClassID:

20505 ⎘

A61K31/683 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Phosphorus compounds Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols

Sub-classes:
Recent Application in this class:
#1
20260130930
2026-05-14

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING RESPIRATORY RELATED DISEASES AND CONDITIONS WITH XYLITOL-HEADGROUP LIPID ANALOGS

 #2
20260097053
2026-04-09

COMPOSITIONS AND METHODS FOR MODULATING CHOLESTEROL EFFLUX

 #3
20260069620
2026-03-12

IMMUNOTHERAPEUTIC PHOSPHOLIPIDS FOR CANCER TREATMENT

 #4
20260041650
2026-02-12

COMPOSITION FOR LIVING BODY

 #5
20260015322
2026-01-15

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

 #6
20250388571
2025-12-25

AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF

 #7
20250346615
2025-11-13

GLYCEROPHOSPHOINOSITOL IN PREVENTING AND TREATING COVID-19 INFECTIONS AND METHOD FOR OBTAINING IT

 #8
20250213577
2025-07-03

ALPHA POLYGLUTAMATED LOMETREXOL AND USES THEREOF

 #9
20250154166
2025-05-15

HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR

 #10
20250099494
2025-03-27

PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF, AND PREPARATION METHODS FOR AND USES OF PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF

 #11
20250082639
2025-03-13

ALPHA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

 #12
20250049825
2025-02-13

Surfactant Lipids, Compositions Thereof, and Uses Thereof

 #13
20250041319
2025-02-06

BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS

 #14
20250032503
2025-01-30

USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE

 #15
20250009699
2025-01-09

LIPID EMULSIONS FOR PARENTERAL NUTRITION

 #16
20240382504
2024-11-21

TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS

 #17
20240358727
2024-10-31

MICROSCALE THERMOPHORESIS TO EVALUATE CHANNEL LIPID INTERACTIONS AND METHODS OF TREATING NAV CHANNELS RELATED DISEASES

 #18
20240299428
2024-09-12

FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST FILOVIRUSES AND FLAVIVIRUSES

 #19
20240277737
2024-08-22

METHOD FOR GENERATING DRY POWDER SUITABLE FOR INHALATION ADMINISTRATION OF ANTIMICROBIAL PHOSPHOLIPID COMPOSITIONS

 #20
20240261308
2024-08-08

TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS

 #21
20240189366
2024-06-13

BIOEFFECTIVE KRILL OIL COMPOSITIONS

 #22
20240189332
2024-06-13

COMPOSITIONS FOR THE TREATMENT OF FIBROSIS

 #23
20240180936
2024-06-06

Treating pain associated with chemotherapy-induced peripheral neuropathy

 #24
20240122951
2024-04-18

METHOD TO TREAT LIPID DYSREGULATION BY MODULATING ACTIVITY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PROTEIN WITH SMALL MOLECULE LIGANDS

 #25
20240091251
2024-03-21

COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS

 #26
20240091242
2024-03-21

LIPIDS THAT REDUCE LUNG DAMAGE, IMPROVE PULMONARY FUNCTION AND DECREASE PRO-INFLAMMATORY CYTOKINES

 #27
20240082276
2024-03-14

LIPID COMPOSITIONS

 #28
20240041906
2024-02-08

PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTIONS

 #29
20240041812
2024-02-08

BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS

 #30
20240033241
2024-02-01

COMPOSITION FOR EXTERNAL USE ON SKIN FOR INFLAMMATORY DISEASES

 #31
20240024266
2024-01-25

Therapeutic Agent or Prophylactic Agent for COVID-19

 #32
20230405027
2023-12-21

INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS

 #33
20230404976
2023-12-21

PHARMACEUTICAL COMBINATION CONTAINING CAPSID PROTEIN INHIBITOR AND NUCLEOSIDE ANALOG

 #34
20230390313
2023-12-07

METHODS OF PREVENTING HIV INFECTIONS IN HUMANS

 #35
20230382909
2023-11-30

BICYCLIC COMPOUNDS

 #36
20230321073
2023-10-12

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DYSREGULATION

 #37
20230310469
2023-10-05

METHODS OF TREATING SYMPTOMS OF CORONAVIRUS INFECTION WITH TOLL-LIKE-RECEPTOR AGONISTS

 #38
20230295202
2023-09-21

Cyclobutyl purine derivative or salt thereof

 #39
20230263179
2023-08-24

INFANT FORMULA MILK POWDER RICH IN MILK FAT GLOBULE MEMBRANE PROTEIN, PHOSPHOLIPIDS AND OLIGOSACCHARIDES AND PREPARATION METHOD THEREFOR

 #40
20230190672
2023-06-22

PHARMACEUTICAL OPHTHALMIC COMPOSITIONS FOR PROTECTION AGAINST BLUE LIGHT

 #41
20230151048
2023-05-18

Crystal form, preparation method, and application of 4'-substituted nucleoside

 #42
20230137543
2023-05-04

Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels

 #43
20230119248
2023-04-20

MATERIALS AND METHODS FOR IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT-TARGETED CANCER THERAPY

 #44
20230041432
2023-02-09

COMPOSITIONS COMPRISING POLAR LIPIDS FOR MAINTAINING OR INCREASING MOBILITY AND VITALITY

 #45
20230024058
2023-01-26

COMPOSITION THAT PROMOTE PRO-RESOLVING MEDIATORS

 #46
20220409587
2022-12-29

METHODS OF TREATING HIV-1 INFECTION

 #47
20220378808
2022-12-01

FOSPROPOFOL FORMULATIONS

 #48
20220362266
2022-11-17

Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors

 #49
20220354873
2022-11-10

METHODS FOR THE PREPARATION OF RIBOSIDES

 #50
20220354789
2022-11-10

Immune stimulating micelle composition

 #51
20220339173
2022-10-27

ORAL COMPOSITION FOR IMPROVING MEMORY-LEARNING ABILITY

 #52
20220280549
2022-09-08

Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

 #53
20220273681
2022-09-01

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING RESPIRATORY RELATED DISEASES AND CONDITIONS WITH XYLITOL-HEADGROUP LIPID ANALOGS

 #54
20220265672
2022-08-25

Use of aprepitant for treating Alzheimer's disease

 #55
20220249525
2022-08-11

Fatty Acid Compounds for Prevention and Treatment of Neurodegenerative Disorders

 #56
20220241302
2022-08-04

Surfactant Lipids, Compositions Thereof, and Uses Thereof

 #57
20220233542
2022-07-28

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION

 #58
20220226367
2022-07-21

THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION

 #59
20220211730
2022-07-07

TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS

 #60
20220152157
2022-05-19

COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS

 #61
20220151984
2022-05-19

Pharmaceutical composition containing silybin and VE

 #62
20220133756
2022-05-05

Flex-nucleoside analogues, novel therapeutics against filoviruses and flaviviruses

 #63
20220133755
2022-05-05

Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor

 #64
20220133691
2022-05-05

LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREAST CANCER AND OTHER MALIGNANCIES

 #65
20220125808
2022-04-28

LIPID COMPOSITIONS WITH HIGH DHA CONTENT

 #66
20220096420
2022-03-31

Acetylcholinesterase Inhibitors for Treatment of Dermatological Conditions

 #67
20220034903
2022-02-03

Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy

 #68
20220016141
2022-01-20

METHODS OF PREVENTING HIV INFECTIONS IN HUMANS

 #69
20220016140
2022-01-20

INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS

 #70
20220016139
2022-01-20

METHODS OF INHIBITING HIV INFECTIONS BY PRE-EXPOSURE PROPHYLAXIS

 #71
20210401858
2021-12-30

PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTIONS

 #72
20210401794
2021-12-30

Methods of Using Cannabinoid Compositions for Inducing and Promoting Sleep

 #73
20210393655
2021-12-23

Vesicular Formulations for Use in the Treatment of Pain or Reduced Mobility of a Joint

 #74
20210393654
2021-12-23

Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors

 #75
20210393631
2021-12-23

INTEGRASE INHIBITORS FOR THE PREVENTION OF HIV

 #76
20210379005
2021-12-09

Esters for treatment of ocular inflammatory conditions

 #77
20210369755
2021-12-02

4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication

 #78
20210361680
2021-11-25

INOSITOL-BASED IMMUNOTHERAPIES

 #79
20210353651
2021-11-18

Compounds, derivatives, and analogs for cancer

 #80
20210346350
2021-11-11

Methods and compositions for treatment of glaucoma and related conditions

 #81
20210346330
2021-11-11

Composition for external use on skin for inflammatory diseases

 #82
20210340545
2021-11-04

METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF RESPIRATORY INFECTIONS

 #83
20210338675
2021-11-04

Alpha polyglutamated lometrexol and uses thereof

 #84
20210292347
2021-09-23

DIHETEROCYCLIC TRIAZINONE NUCLEOSIDE ANALOGS AND THEIR USE FOR MEDICATION

 #85
20210275551
2021-09-09

Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands

 #86
20210244696
2021-08-12

Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels

 #87
20210205373
2021-07-08

Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions

 #88
20210198239
2021-07-01

COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR

 #89
20210196733
2021-07-01

Methods to reduce complications of intra-articular steroid

 #90
20210169961
2021-06-10

HEPATOPROTECTIVE TRADITIONAL CHINESE MEDICINE COMPOSITION, EXTRACT THEREOF, AND PHARMACEUTICAL USE THEREOF

 #91
20210169887
2021-06-10

Alpha polyglutamated methotrexate and uses thereof

 #92
20210145741
2021-05-20

ANTIFIBROTIC COMPOSITION

 #93
20210085698
2021-03-25

Lipid compositions

 #94
20210077559
2021-03-18

Treating Autoimmune Disorders with Acetylcholinesterase Inhibitors

 #95
20210052613
2021-02-25

Methods for treating virus infections

 #96
20210040096
2021-02-11

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

 #97
20210030774
2021-02-04

Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor

 #98
20210008085
2021-01-14

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

 #99
20210000913
2021-01-07

Animal feed additive and animal feed

 #100
20210000846
2021-01-07

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

 #101
20200397804
2020-12-24

TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS

 #102
20200390775
2020-12-17

Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

 #103
20200361947
2020-11-19

Bicyclic and tricyclic compounds

 #104
20200360420
2020-11-19

Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

 #105
20200347051
2020-11-05

Solid forms of a toll-like receptor modulator

 #106
20200316194
2020-10-08

Treatment of infection

 #107
20200297744
2020-09-24

Surfactant Lipids, Compositions Thereof, and Uses Thereof

 #108
20200281885
2020-09-10

Acetylcholinesterase inhibitors for treatment of dermatological conditions

 #109
20200268775
2020-08-27

Lipid supplements for reducing nerve action potentials

 #110
20200261503
2020-08-20

CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE THEREOF

 #111
20200261480
2020-08-20

Pharmaceutical composition for preventing or treating adverse drug reactions by statin

 #112
20200261432
2020-08-20

Substituted pyridinone-containing trycyclic compounds, and methods using same

 #113
20200253995
2020-08-13

Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands

 #114
20200246360
2020-08-06

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

 #115
20200230179
2020-07-23

COMPOSITION FOR RELIEVING AND TREATING BURNS AND BEDSORES

 #116
20200222357
2020-07-16

Esters for Treatment of Ocular Inflammatory Conditions

 #117
20200214978
2020-07-09

Functional chewing gum comprising phytonutrients and adaptogenic herbs

 #118
20200206178
2020-07-02

Esters for treatment of ocular inflammatory conditions

 #119
20200197431
2020-06-25

4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication

 #120
20200197422
2020-06-25

METHODS FOR THE PREPARATION OF RIBOSIDES

 #121
20200197421
2020-06-25

METHODS OF INHIBITING HIV INFECTIONS BY PRE-EXPOSURE PROPHYLAXIS

 #122
20200197420
2020-06-25

METHODS OF PREVENTING HIV INFECTIONS IN HUMANS

 #123
20200197419
2020-06-25

PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTIONS

 #124
20200197409
2020-06-25

HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR

 #125
20200179440
2020-06-11

THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION

 #126
20200179413
2020-06-11

Surfactant Lipids, Compositions Thereof, and Uses Thereof

 #127
20200179412
2020-06-11

Compositions for the treatment of fibrosis

 #128
20200179291
2020-06-11

Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine

 #129
20200171060
2020-06-04

Flex-nucleoside analogues, novel therapeutics against filoviruses and flaviviruses

 #130
20200138719
2020-05-07

TENOFOVIR GRANULES

 #131
20200121701
2020-04-23

Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors

 #132
20200108038
2020-04-09

Composition for external use on skin for inflammatory diseases

 #133
20200101093
2020-04-02

Methods of Treating and Preventing Neuropsychiatric and/or Neurocognitive Complications in Patients Infected with HIV

 #134
20200101091
2020-04-02

Acylnucleoside phosphonates, prodrugs thereof and use thereof as medicament

 #135
20200062790
2020-02-27

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

 #136
20200016214
2020-01-16

Phospholipid compositions and their preparation

 #137
20200009165
2020-01-09

Methods and compositions for treating and preventing respiratory related diseases and conditions with xylitol-headgroup lipid analogs

 #138
20200000857
2020-01-02

FLOWABLE CONCENTRATED PHOSPHOLIPID KRILL OIL COMPOSITION

 #139
20190388443
2019-12-26

Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor

 #140
20190367541
2019-12-05

NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS

 #141
20190358248
2019-11-28

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

 #142
20190345190
2019-11-14

PHOSPHONATE ANALOGS OF HIV INHIBITOR COMPOUNDS

 #143
20190343850
2019-11-14

Method of treating glycogen storage disease

 #144
20190330333
2019-10-31

Cognitive function improving agent

 #145
20190328698
2019-10-31

Esters for treatment of ocular inflammatory conditions

 #146
20190322666
2019-10-24

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

 #147
20190321366
2019-10-24

Modulators of toll-like receptors

 #148
20190320975
2019-10-24

Liposomal mitigation of drug-induced inhibition of the cardiac Ichannel

 #149
20190314347
2019-10-17

Substituted pyridinone-containing trycyclic compounds, and methods using same

 #150
20190290666
2019-09-26

Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor

 #151
20190289893
2019-09-26

Nutritional composition for improving cell membranes

 #152
20190275063
2019-09-12

Methods for treating filoviridae virus infections

 #153
20190275052
2019-09-12

COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND A NUCLEOS(T)IDE ANALOGUE

 #154
20190269708
2019-09-05

INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS

 #155
20190254994
2019-08-22

Nutritional composition and infant formula for promoting myelination of the brain

 #156
20190254977
2019-08-22

Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine

 #157
20190231743
2019-08-01

LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREAST CANCER AND OTHER MALIGNANCIES

 #158
20190216808
2019-07-18

Hepatitis B antiviral agents

 #159
20190209592
2019-07-11

BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS

 #160
20190201430
2019-07-04

TREATING OCULAR NEOVASCULARIZATION

 #161
20190185498
2019-06-20

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

 #162
20190169124
2019-06-06

Derivatives of indole for the treatment of cancer, viral infections and lung diseases

 #163
20190167585
2019-06-06

Protective Effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC Against Drugs that Cause Channelopathies

 #164
20190144473
2019-05-16

Amino compounds for treatment of complement mediated disorders

 #165
20190085005
2019-03-21

Phosphonate compounds for treatment of complement mediated disorders

 #166
20190083525
2019-03-21

Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

 #167
20190083515
2019-03-21

Thyromimetics for the treatment of fatty liver diseases

 #168
20190060335
2019-02-28

Oral lipid supplements for treating pain and fibromyalgia

 #169
20190060332
2019-02-28

Concentrated therapeutic phospholipid compositions

 #170
20190048033
2019-02-14

Ether compounds for treatment of complement mediated disorders

 #171
20190031692
2019-01-31

Compounds for treatment of complement mediated disorders

 #172
20190030088
2019-01-31

Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions

 #173
20190030056
2019-01-31

Methods and compounds for treating malaria

 #174
20190023729
2019-01-24

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

 #175
20190022113
2019-01-24

Compositions and methods of treating HIV

 #176
20190015433
2019-01-17

Lipid compositions with high DHA content

 #177
20190015420
2019-01-17

CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE

 #178
20190008878
2019-01-10

COMPOSITIONS AND METHOD FOR REDUCING CARDIOTOXICITY

 #179
20180353601
2018-12-13

Treatment of infection

 #180
20180353551
2018-12-13

FLOWABLE CONCENTRATED PHOSPHOLIPID KRILL OIL COMPOSITION

 #181
20180325927
2018-11-15

Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors

 #182
20180311288
2018-11-01

Bioeffective krill oil compositions

 #183
20180311263
2018-11-01

Methods for treating Filoviridae virus infections

 #184
20180306821
2018-10-25

DIAGNOSTIC MARKER FOR CORONARY ARTERY DISEASE

 #185
20180303881
2018-10-25

Flowable concentrated phospholipid krill oil composition

 #186
20180303856
2018-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

 #187
20180303855
2018-10-25

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

 #188
20180298043
2018-10-18

Alkyne Compounds for Treatment of Complement Mediated Disorders

 #189
20180291047
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

 #190
20180291046
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

 #191
20180289726
2018-10-11

Antibacterial agent against multidrug-resistant gram-positive bacteria and external agent

 #192
20180280538
2018-10-04

Expression of HIV inhibitors by mesenchymal stem cells

 #193
20180264015
2018-09-20

Leukocyte infiltration promoting agent and antitumor immunostimulatory agent

 #194
20180256612
2018-09-13

Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor

 #195
20180243443
2018-08-30

Nanoparticle conjugates and uses thereof

 #196
20180243345
2018-08-30

METHOD FOR INCREASING MUSCLE GROWTH USING KRILL EXTRACT

 #197
20180214378
2018-08-02

Tenofovir granules

 #198
20180207284
2018-07-26

Fluorescent prodrugs

 #199
20180193461
2018-07-12

Pharmaceutical compositions to reduce complications of ocular steroid

 #200
20180193389
2018-07-12

Bioeffective krill oil compositions

 #201
20180193366
2018-07-12

Inhibition of HIV infection through chemoprophylaxis

 #202
20180177807
2018-06-28

Surfactant lipids, compositions thereof, and uses thereof

 #203
20180169127
2018-06-21

Compositions and methods that modulate white blood cells or neutrophils in a companion animal

 #204
20180161297
2018-06-14

Benefits of supplementation with N-acetylcysteine and glycine to improve glutathione levels

 #205
20180153936
2018-06-07

COMPOSITIONS AND METHODS OF USING LAMELLAR BODIES FOR MODIFYING LINEAR BIOLOGICAL MACROMOLECULES

 #206
20180133287
2018-05-17

NUTRITIONAL COMPOSITIONS PROVIDING DIETARY MANAGEMENT OF COLIC

 #207
20180133263
2018-05-17

PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION

 #208
20180133233
2018-05-17

Bicyclic aryl sphingosine 1-phosphate analogs

 #209
20180104216
2018-04-19

Pharmaceutical composition containing silibinin and pueraria root extract

 #210
20180104215
2018-04-19

Pharmaceutical composition containing silybin and L-carnitine

 #211
20180099967
2018-04-12

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

 #212
20180085370
2018-03-29

Modulators of toll-like receptors

 #213
20180085309
2018-03-29

Pet hydration system

 #214
20180072762
2018-03-15

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

 #215
20180065986
2018-03-08

Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate

 #216
20180055817
2018-03-01

Pharmaceutical composition containing silybin, VE and L-carnitine

 #217
20180055770
2018-03-01

Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies

 #218
20180051043
2018-02-22

Phosphate substituted quinolizine derivatives useful as HIV integrase inhibitors

 #219
20180050051
2018-02-22

Fumagillol derivatives

 #220
20180050015
2018-02-22

Pharmaceutical composition containing silybin and ve

 #221
20180042892
2018-02-15

Pharmaceutical composition containing silibinin

 #222
20180030075
2018-02-01

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

 #223
20180030073
2018-02-01

Natural lipids containing non-oxidizable fatty acids

 #224
20180022769
2018-01-25

Fluorine-containing bisphosphonic acid derivative and use thereof

 #225
20180022767
2018-01-25

Compounds for treatment of complement mediated disorders

 #226
20180022766
2018-01-25

Ether compounds for treatment of complement mediated disorders

 #227
20170354668
2017-12-14

Synthesis method for improved tenofovir disoproxil fumarate using ion-exchange resin and method for preparing oral dissolving film form using the same

 #228
20170342411
2017-11-30

Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections

 #229
20170334924
2017-11-23

Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors

 #230
20170333438
2017-11-23

Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13A- octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamide

 #231
20170319608
2017-11-09

Chewable lipid supplements for treating pain and fibromyalgia

 #232
20170319607
2017-11-09

Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids

 #233
20170304409
2017-10-26

COMPOSITIONS USEFUL FOR THE PREVENTION AND/OR TREATMENT OF INFECTIONS AND INFLAMMATIONS

 #234
20170298085
2017-10-19

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

 #235
20170298084
2017-10-19

Amide compounds for treatment of complement mediated disorders

 #236
20170273994
2017-09-28

Compositions and Methods for Combination Antiviral Therapy

 #237
20170266156
2017-09-21

METHOD FOR PREVENTING CANCER BY USING PHTHALIDES

 #238
20170266155
2017-09-21

Method for enhancing the oxygenation level of tissue cells as an alternative method for hyperbaric oxygen therapy

 #239
20170260219
2017-09-14

Phosphonate compounds for treatment of complement mediated disorders

 #240
20170246196
2017-08-31

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

 #241
20170240575
2017-08-24

Chemical inhibitors of sebocyte function

 #242
20170239280
2017-08-24

Bicyclic aryl sphingosine 1-phosphate analogs

 #243
20170233342
2017-08-17

Derivatives of indole for the treatment of cancer, viral infections and lung diseases

 #244
20170232019
2017-08-17

Compositions and Methods for Combination Antiviral Therapy

 #245
20170216326
2017-08-03

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

 #246
20170216322
2017-08-03

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

 #247
20170190701
2017-07-06

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

 #248
20170189410
2017-07-06

Amino compounds for treatment of complement mediated disorders

 #249
20170182074
2017-06-29

Liquid phospholipid-containing compositions for the preparation of pharmaceuticals

 #250
20170173148
2017-06-22

Treatment of infection

 #251
20170157164
2017-06-08

Method for reducing white matter lesions, white matter hyperintensities (WMH), leukoaraiosis or periventricular white matter disease in elderly

 #252
20170157163
2017-06-08

METHOD FOR TREATING, STABILIZING OR SLOWING DOWN BRAIN GLUCOSE METABOLISM DEFICIT

 #253
20170151203
2017-06-01

Infant nutrition for improving fatty acid composition of brain membranes

 #254
20170135978
2017-05-18

Acetylcholinesterase inhibitors for treatment of dermatological conditions

 #255
20170119802
2017-05-04

Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel

 #256
20170119721
2017-05-04

Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof

 #257
20170112948
2017-04-27

Inorganic-organic hybrid compound

 #258
20170112864
2017-04-27

Thyromimetics for the treatment of fatty liver diseases

 #259
20170095489
2017-04-06

Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies

 #260
20170087179
2017-03-30

Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion

 #261
20170079999
2017-03-23

UNITARY PHARMACEUTICAL DOSAGE FORM

 #262
20170079993
2017-03-23

Lipid compositions with high DHA content

 #263
20170071968
2017-03-16

Pharmaceutical composition based on a hepatoprotector and prebiotic, and method for administrating

 #264
20170065645
2017-03-09

Krill oil preparations and their uses

 #265
20170065592
2017-03-09

MODULATORS OF TOLL-LIKE RECEPTORS

 #266
20170042926
2017-02-16

Treating ocular neovascularization

 #267
20170042915
2017-02-16

LPA RECEPTOR MODULATORS FOR BROWN FAT DIFFERENTIATION

 #268
20170035887
2017-02-09

Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies

 #269
20170035788
2017-02-09

Vesicular Formulations

 #270
20170027947
2017-02-02

Chewable lipid supplements containing caffeine for increasing alertness, focus and energy

 #271
20170020928
2017-01-26

Flowable concentrated phospholipid krill oil composition

 #272
20170014408
2017-01-19

Hepatitis B antiviral agents

 #273
20160375132
2016-12-29

Homogenous suspension of immunopotentiating compounds and uses thereof

 #274
20160375043
2016-12-29

Concentrated therapeutic phospholipid compositions

 #275
20160367590
2016-12-22

Phospholipid compositions and use thereof to enhance spermatozoa motility and viability

 #276
20160362398
2016-12-15

Amide compounds for treatment of complement mediated disorders

 #277
20160361329
2016-12-15

COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

 #278
20160361270
2016-12-15

UNIFORM, HIGH BASIS WEIGHT NANOFIBER FABRICS FOR MEDICAL APPLICATIONS

 #279
20160355515
2016-12-08

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

 #280
20160339062
2016-11-24

Phospholipid compositions and their preparation

 #281
20160339043
2016-11-24

Compositions and methods for reducing intraocular pressure

 #282
20160333013
2016-11-17

Tricyclic compounds as anticancer agents

 #283
20160331772
2016-11-17

Composition Comprising a Uridine Source, an Omega-3 PUFA for Improving Coordination, Balance, Grip Strength or Fine Motor Skills

 #284
20160318861
2016-11-03

Prodrugs of dithiol mucolytic agents

 #285
20160303159
2016-10-20

Pyrimidine derivative and a fatty acid source for use in the treatment of constipation

 #286
20160287686
2016-10-06

MYELOID DERIVED SUPPRESSOR CELL INHIBITING AGENTS

 #287
20160281026
2016-09-29

Bioeffective krill oil compositions

 #288
20160279173
2016-09-29

Bioeffective krill oil compositions

 #289
20160263132
2016-09-15

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

 #290
20160228462
2016-08-11

Lipid compositions

 #291
20160228461
2016-08-11

Lipid extraction processes

 #292
20160219915
2016-08-04

Nutritional compositions with coated lipid globules

 #293
20160205983
2016-07-21

Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids

 #294
20160184330
2016-06-30

Suppression of cytokine release and cytokine storm

 #295
20160175332
2016-06-23

Fumagillol derivatives

 #296
20160166591
2016-06-16

Compositions and methods to treat cardiac diseases

 #297
20160129023
2016-05-12

Bicyclic aryl sphingosine 1-phosphate analogs

 #298
20160122356
2016-05-05

Methods for the preparation of ribosides

 #299
20160120888
2016-05-05

ANTICANCER DRUG

 #300
20160106768
2016-04-21

Lysophospholipids and lysophospholipid analogues against honeybee brood diseases